DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$42,459,000
+1.4%
300,000
-28.6%
0.75%
-14.3%
Q1 2021$41,874,000
+5.9%
420,000
+31.2%
0.88%
+12.5%
Q4 2020$39,558,000
-9.4%
320,000
-28.6%
0.78%
-26.4%
Q3 2020$43,644,000
+6.9%
448,000
+71.1%
1.06%
-10.6%
Q2 2020$40,841,000
+53.9%
261,765
+42.4%
1.19%
+41.2%
Q1 2020$26,539,000
+29.8%
183,865
+83.9%
0.84%
+29.1%
Q4 2019$20,443,000
+29.2%
100,000
-49.2%
0.65%
+1.1%
Q3 2019$15,817,000
-14.9%
197,0000.0%0.64%
-3.4%
Q2 2019$18,587,000
-40.3%
197,000
-45.9%
0.67%
-44.0%
Q1 2019$31,111,000
+52.4%
364,0000.0%1.19%
+46.0%
Q4 2018$20,420,000
-15.0%
364,000
+23.8%
0.82%
-5.1%
Q3 2018$24,037,000
+12.8%
294,000
-51.8%
0.86%
+15.0%
Q2 2018$21,316,000
+166.5%
609,554
+56.3%
0.75%
+170.4%
Q1 2018$7,999,000
-27.6%
390,0000.0%0.28%
-36.3%
Q4 2017$11,045,000
+86.9%
390,000
+105.3%
0.44%
+63.5%
Q3 2017$5,909,000190,0000.27%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders